Evidence map›Paper›PMID 31817324›Full record

SynthesisInternational journal of environmental research and public health2019

Effects of

Amiza Hamdan, Ruszymah Haji Idrus, Mohd Helmy Mokhtar

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in International journal of environmental research and public health, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed, 2 pooled it
12.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed, 2 syntheses or guidelines pooled it, 93 citations in OpenAlex.

  1. Pooled it
  2. International journal of molecular sciences · 2022
    Pooled it
  3. Review
  4. Harnessing the Hepatoprotective and Nephroprotective Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. International journal of molecular sciences · 2024
    Review
  9. Review
  10. Article
  11. Article
  12. The Use ofBiomedicines · 2024
    Review
  13. Article
  14. Potential Pharmacological Applications ofPlants (Basel, Switzerland) · 2023
    Review
  15. A Review of the Potential Health Benefits ofPlants (Basel, Switzerland) · 2023
    Review
  16. Review
  17. Effect ofCurrent issues in molecular biology · 2023
    Review
  18. Synergistic Effects of Nigella sativa and Exercise on Diabetic Profiles: A Systematic Review.Diabetes therapy : research, treatment and education of diabetes and related disorders · 2023
    Review
  19. Article
  20. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Amiza HamdanDepartment of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
Ruszymah Haji IdrusDepartment of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
Mohd Helmy MokhtarDepartment of Physiology, Faculty of Medicine, Universiti Kebangsaan Malaysia, Kuala Lumpur 56000, Malaysia.
National University of Malaysia · MY

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus is one of the most prevalent metabolic disorders that affect people of all genders, ages, and races. Medicinal herbs have gained wide attention from researchers and have been considered to be a beneficial adjuvant agent to oral antidiabetic drugs because of their integrated effects. Concerning the various beneficial effects of

Indexed as

Nigella sativaBlood GlucoseDiabetes Mellitus, Type 2Glycated HemoglobinHumansHypoglycemic AgentsInsulin ResistanceMalePlant ExtractsPlants, MedicinalBlood GlucoseGlycated HemoglobinHypoglycemic AgentsPlant Extractsantidiabetichypoglycemic effectNigella sativathymoquinoneType-2 diabetes mellitus

Identifiers

PMID31817324
PMCPMC6950756
OpenAlexW2994420236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.